SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

Pojak ($PJ) is gaining attention as community members highlight its clean chart and potential for significant upside. The growing community believes early buyers will benefit, with some suggesting smart money is accumulating the token. Cautionary voices advise vigilance, but overall sentiment suggests building momentum.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is trending due to potential US and Australian rare earth deals, with community members speculating on upcoming meetings and long-term supply agreements. Some investors are discussing the recent price drop as a profit-taking opportunity, while others highlight the company's strong fundamentals and increasing demand for rare earth materials. The community also discusses potential partnerships and expansions, especially the U.S. plant.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending due to a recent record-breaking contract and regained NASDAQ compliance, fueling speculation of a potential short squeeze. The stock's low float and high cost to borrow are driving community interest, with comparisons being made to other Hong Kong-based stocks that have experienced significant gains. Traders are closely watching for a potential breakout, especially as it trends as the #1 most watched ticker on social media.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets (SSB) is trending as community members discuss new coins launching on Phantom Wallet and those building momentum. Several coins, including $1DOG, $CHINAWINS, and $KABOOM, are generating significant buzz within the SSB community. Discussions also highlight projects focusing on community building and locked liquidity, reflecting a growing interest in projects prioritizing trust and transparency.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending as investors discuss its future growth potential amid mixed sentiments around revenue guidance and a discount program impacting profitability. The community is actively analyzing the implications of the CHOPIN trial data expected at #esmo2025, which could significantly expand the use of their Hepzato Kit, and whether it might attract buyout interest. Discussions also involve revenue expectations, potential cash flow, and the impact of expanded clinical trials on the company's financial strategy.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending as the community discusses its potential breakout, with some traders highlighting significant call option activity suggesting bullish sentiment; however, caution is advised due to recent price pullbacks. Community members are weighing IBIT's prospects against those of gold and other crypto investment vehicles amid broader market uncertainties and upcoming economic announcements. Some analysts believe Bitcoin ETFs could see massive inflows if the Federal Reserve cuts rates.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as community members discuss its AI leadership and potential for growth, particularly with Gemini and new AI integrations.  Some analysts have raised price targets, citing the company's strong advertising business and advancements in AI hardware.  Despite positive sentiment, some traders note the stock's recent underperformance relative to peers and broader market indices.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon ($LULU) is trending as the stock price hovers near 5-year lows, sparking debates about a potential turnaround versus further declines. Community discussions revolve around tariff impacts, competition from other brands, and the possibility of activist investor involvement. Some traders point to technical indicators suggesting a possible relief rally, while others remain bearish, citing weak price action and fading brand appeal.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT) is trending as the community discusses its potential and the benefits of earning crypto through walking. Some investors express patience and optimism, anticipating future growth, while others highlight the project's fundamentals. Discussions also mention staking and long-term holding strategies within the Sweat Economy.

Westinghouse Air Brake Technologies Corp. engages in the provision of equipment, systems, and value-added services for the rail industry. It operates through the Freight and Transit segments. The Freight segment builds new locomotives, manufactures and services components for new and existing freight cars and locomotives, rebuilds freight locomotives, supplies railway electronics, positive train control equipment, and signal design and engineering services, and provides related heat exchange and cooling systems. The Transit segment manufactures and services components for new and existing passenger transit vehicles, including regional trains, high speed trains, subway cars, light-rail vehicles, and buses, builds new commuter locomotives, refurbishes subway cars, and provides heating, ventilation, air conditioning equipment, and doors for buses and subway cars. The company was founded in 1869 and is headquartered in Pittsburgh, PA.

Westinghouse Air Brake Technologies Corp

Wabtec is trending due to a recent $4.2 billion locomotive deal with Kazakhstan's KTZ, driving optimism about the company's role in global rail modernization. The community is discussing the deal's impact on Wabtec's position as a leading rail technology innovator and comparing it favorably to other dividend stocks. Analysts are also weighing in with updated ratings and price targets, adding to the increased attention on WAB.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?

ALNY's portfolio of rare disease and cardiovascular drugs is boosting revenues and reducing reliance on Amvuttra.

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Alnylam's strong drug sales and advancing partnerships with Regeneron and Roche highlight key growth drivers in the quarters ahead.

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.

BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -14.46% and +14.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?

BridgeBio Pharma (BBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Starbucks, Freeport-McMoran and Verona Pharma rise premarket;  WPP, T-Mobile fall

Investing.com -- U.S. stock futures edged higher Wednesday in calm trading, as investors assessed the new developments in the Trump administration’s trade negotiations ahead of the release of the minutes from the last Federal Reserve meeting.

Bayer Begins Phase I Study on BAY 3670549 in Atrial Fibrillation

Are Medical Stocks Lagging  Alignment Healthcare (ALHC) This Year?

Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to Trade

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$54.92
Prev Close	$55.03
Open	$54.35
Dividend Yield	0.00%
50-Day Moving Average	$51.88
Beta	1.48
Avg. Volume	2.36M
PE Ratio	-13.41

52-Week High	$57.49
52-Week Low	$21.72
Market Capitalization	$10.5B
EPS (Annual)	-$2.88
Price to Book	-5.87
Revenue Per Employee	$303,975.34
Enterprise Value/EBITDA	N/A

BBIO
BridgeBio Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBIO News

BBIOBridgeBio Pharma Inc